Clinical trial
Benefit of a Systematic Proposition of Nicotine Replacement Therapy Preoperatively for Patients Undergoing Planned Surgery and With Tobacco or Cannabis Addiction, Regardless of the Intention to Quit
NCT04572646 is registered in ClinicalTrials.gov with Groupe Hospitalier Mutualiste de Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benefit of a Systematic Proposition of Nicotine Replacement Therapy Preoperatively for Patients Undergoing Planned Surgery and With Tobacco or Cannabis Addiction, Regardless of the Intention to Quit
- Lead sponsor
- Groupe Hospitalier Mutualiste de Grenoble
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 24, 2020
- Completion date
- May 31, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation